ArticleCancer chemotherapy and pharmacology2023

The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database.

Masami Tsuchiya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.